SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.

Dong H, Wang W, Mo S, Chen R, Zou K, Han J, Zhang F, Hu J.

Open source

DOI
10.1186/s13046-018-0875-3
Published
2018-08-29
Container
J Exp Clin Cancer Res
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 18/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13046-018-0875-3,
  title = {SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.},
  author = {Dong H and  Wang W and  Mo S and  Chen R and  Zou K and  Han J and  Zhang F and  Hu J.},
  year = {2018},
  journal = {J Exp Clin Cancer Res},
  doi = {10.1186/s13046-018-0875-3},
  url = {https://doi.org/10.1186/s13046-018-0875-3}
}

RIS

TY  - JOUR
TI  - SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.
AU  - Dong H
AU  -  Wang W
AU  -  Mo S
AU  -  Chen R
AU  -  Zou K
AU  -  Han J
AU  -  Zhang F
AU  -  Hu J.
PY  - 2018
JO  - J Exp Clin Cancer Res
DO  - 10.1186/s13046-018-0875-3
UR  - https://doi.org/10.1186/s13046-018-0875-3
ER  - 

APA

H, D., W, W., S, M., R, C., K, Z., J, H., F, Z., & J., H. (2018). SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.. J Exp Clin Cancer Res. https://doi.org/10.1186/s13046-018-0875-3

Source records